NIVFW
NewGenIvf Group Limited WarrantsNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
0.09
52W High
$0.04
52W Low
$0.01
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
209.00%
Forward P/E
—
PEG Ratio
—
About NewGenIvf Group Limited Warrants
NewGenIvf Group Limited Warrants (NIVFW) is a leading biotechnology company committed to transforming the landscape of reproductive healthcare through advanced assisted reproductive technology (ART). The firm focuses on enhancing the success rates and quality of care for individuals and couples facing infertility challenges by utilizing innovative research and state-of-the-art technology. With a strategic emphasis on addressing the unmet needs within the fertility sector, NewGenIvf is well-positioned to capitalize on the growing global demand for IVF services, aiming to expand its reach through partnerships and service innovations.
Fundamentals
| Revenue (TTM) | $4.73M |
| Gross Profit (TTM) | 955,850 |
| EBITDA | $-10.54M |
| Operating Margin | -349.10% |
| Return on Equity | 79.40% |
| Return on Assets | -36.90% |
| Revenue/Share (TTM) | $102.73 |
| Book Value | $818.78 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 11.90% |
| Shares Outstanding | 0 |
| Float | 568,470 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/9/2026